Filter
894
Text search:
pharmacists
Featured
68
257
Language
Document type
451
160
151
50
30
16
12
10
7
3
2
1
1
Countries
45
43
40
29
25
24
24
24
23
22
18
17
17
16
16
16
14
11
11
10
10
9
8
7
7
7
7
6
5
5
5
5
5
5
5
5
4
4
4
4
4
3
3
3
3
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
Authors & Publishers
Publication Years
Category
424
58
40
36
21
19
12
2
1
Toolboxes
119
99
46
42
29
27
27
23
17
12
9
7
7
4
4
3
2
2
2
1
1
1
Examination of the business behavior of Boehringer Ingelheim, Bayer and Baxter in India
Strengthening Facility Based Pediatric Care
recommended
Operational Guidelines for Planning and Implementation in District Hospitals
Celebrating ten years of success 2004-2014
Towards the Peoples Health Assembly Book -5
The results of in-country database and reports analysis
Results and Lessons Learned from CapacityPlus 2009-2015
The Government of Botswana’s SRH Policy Guidelines and Service Standards document provides the framework for developing a responsive strategy and an implementation plan for SRHR and HIV&AIDS Linkages and Integration. The global call on governments to demonstrate commitments to intensify linkages b
...
The Policy Guidelines and Service Standards for National Sexual and Reproductive Health Programme document outlines the steps on how to offer and deliver services. Improving quality of care is critical to improving clients' health status as well as increasing access to, and utilization of Sexual and
...
Capability and Performance
GOVERNMENT NOTICE | No. 192 Promulgation of Medicines and Related Substances Control Act, 2003 (Act No. 13 of 2003), of the Parliament
“towards quality health and social welfare services”
Second Generation, WHO Country Cooperation Strategy, 2010–2015, Namibia
Accessed November, 2017
Document No. : FDA/SMC/CTD/GL-CCT/2013/01
A survival guide for clinicans.
3rd edition.
Application of a One Health approach .
The present guidance was developed with the support of the WHO Advisory Group on Integrated Surveillance of Antimicrobial Resistance (AGISAR) to assist countries and other stakeholders in the establishment and development of programmes of integrated surveillan
...
Therapeutics Information and Pharmacovigilance Centre | TIPC
A Step-by-Step Guide.
It is intended for health planners, dengue or vector control programme managers and individuals, nongovernmental organizations (NGOs) and other agencies with interests and/or expertise in developing biological, chemical, environmental and communication interventions to prevent
...
Medicines and Allied Substances [No. 3 of 2013 47 | An Act to continue the existence of the Pharmaceutical Regulatory Authority and re-name it as the Zambia Medicines Regulatory Authority; provide for the functions and powers of the Authority; provide for the registration and regulation of pharmacie
...
Made under Section 5 (c) of the Tanzania Food, Drugs and Cosmetics Act, 2003 | Second Edition
The Zimbabwe National Pharmacovigilance Policy Handbook, 2nd Edition updates the November 2013 version to indicate the Zimbabwe National Pharmacovigilance (PV) Centre’s compliance with the WHO Pharmacovigilance Indicators Handbook 2015.
HRH SA 2030 | Draft HR Strategy for the Health Sector: 2012/13 – 2016/17 Consultation Document
What We Know, What We Don’t Know, and What We Need to Do
Standard Operating Procedures for Implementation of TB Activities at HIV/AIDS Service Delivery Sites
Key populations brief
Accessed November 2017
A Handbook for country programmes
Collection of country-level good practices
National Guidelines for HIV & AIDS Care and Treatment (5th Edition)
Overcoming Barriers to TB Control
Training Curriculum
August 2011
Key Populations Brief
Accessed November 2017
End of Project Monograph
Guidance on Implending Publi-Private Mix Approaches
TB policies in 29 Countries
A survey of prevention, testing and treatment policies and practices
Experience of national TB partnerships
South Eastern European Journal of Public Health, EEJPH 2016, posted: 11 January 2016. DOI 10.4119/UNIBI/SEEJPH-2016-85
ERJ Open Res 2017; 3: 00002-2017
Updated to Reflect the 2009 Medical Eligibility Criteria of the World Health Organization
An Act to repeal the Dangerous Medicines Act of 1973,to ensure the availability of certain drugs for exclusive medical, scientific and related purposes, while preventing their abuse; to prevent the diversion from lawful trade of controlled chemicals, controlled equipment and controlled materials for
...
Mission report: June 11-20, 2017
SITUATION ANALYSIS AND RECOMMENDATIONS
Strategy for Increasing the use of Modern Contraceptives in Nigeria
